MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer

Molecular Carcinogenesis

Volumn 55, Issue 12, 2016, Pages 2260-2267

  Zhou, Baoguo ^a   Song, Jianwei ^a   Han, Taotao ^b   Huang, Mingkui ^a   Jiang, Hongpeng ^a   Qiao, Haiquan ^a   Shi, Juan ^b   Wang, Yuli ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

colorectal cancer; MicroRNAs; miR 382; NR2F2

Indexed keywords

CYCLIN D1; GELATINASE B; MICRORNA; MICRORNA 382; NR2F2 PROTEIN; STEROID RECEPTOR; UNCLASSIFIED DRUG; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; MIRN382 MICRORNA, HUMAN; NR2F2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MOTILITY; COLORECTAL CANCER; CONTROLLED STUDY; ECTOPIC EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL MOTION; CELL PROLIFERATION; COLON; COLORECTAL TUMOR; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; METABOLISM; PATHOLOGY; RECTUM; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; COUP TRANSCRIPTION FACTOR II; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RECTUM;

EID: 84994879741     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22466     Document Type: Article

References (26)

1. van Engeland M, Derks S, Smits KM, Meijer GA, Herman JG. Colorectal cancer epigenetics: Complex simplicity. J Clin Oncol 2011; 29:1382–1391.
2. Temraz S, Mukherji D, Shamseddine A. Potential targets for colorectal cancer prevention. Int J Mol Sci 2013; 14:17279–17303.
3. Johnson IT, Belshaw NJ. The effect of diet on the intestinal epigenome. Epigenomics 2014; 6:239–251.
4. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281–297.
5. Frankel LB, Lund AH. MicroRNA regulation of autophagy. Carcinogenesis 2012; 33:2018–2025.
6. Ibrahim SA, Hassan H, Götte M. MicroRNA regulation of proteoglycan functions in cancer. FEBS J 2014; 281:5009–5022.
7. Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol Med 2014; 20:460–469.
8. Zhou HD, Guo WJ, Zhao YJ, et al. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2. Int J Oncol 2014; 44:2050–2058.
9. Huang J, Zhang SY, Gao YM, et al. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: Potential biomarkers and therapeutic targets. Cell Proliferat 2014; 47:277–286.
10. Wang ZH, Ren LL, Zheng P, et al. MiR-194 as a predictor for adenoma recurrence in patients with advanced colorectal adenoma after polypectomy. Cancer Prev Res 2014; 7:607–616.
11. Yong FL, Law CW, Wang CW. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer 2013; 13:280.
12. Xu M, Jin H, Xu CX, et al. MiR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma. Oncotarget 2014; 5:9472–9483.
13. Xu M, Jin H, Xu CX, et al. MiR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1. Mol Ther 2015; 23:89–98.
14. Theriault BL, Basavarajappa HD, Lim H, Pajovic S, Gallie BL, Corson TW. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer. PLoS ONE 2014; 9:e91540.
15. Li S, Meng HM, Zhou F, et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract 2013; 209:179–183.
16. Qin J, Chen XP, Xie X, Tsai MJ, Tsai SY. COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. P Natl Acad Sci USA 2010; 107:3687–3692.
17. Qin J, Chen XP, Yu-Lee LY, Tsai MJ, Tsai SY. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 2010; 70:8812–8821.
18. Nagasaki S, Suzuki T, Miki Y, et al. Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: Possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Cancer Sci 2009; 100:639–645.
19. Qin J, Wu SP, Creighton CJ, et al. COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis. Nature 2013; 493:236–240.
20. Polvani S, Tarocchi M, Tempesti S, et al. COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. Int J Cancer 2014; 134:1648–1658.
21. Bao Y, Gu D, Feng W, et al. COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1. Br J Cancer 2014; 111:933–943.
22. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA-Cancer J Clin 2011; 61:69–90.
23. Seok JK, Lee SH, Kim MJ, Lee YM. MicroRNA-382 induced by HIF-1 alpha is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res 2014; 42:8062–8072.
24. Bringuier PP, Schalken JA, Hervieu V, Giroldi LA. Involvement of orphan nuclear receptor COUP-TFII in cadherin-6 and cadherin-11 regulation: Implications in development and cancer. Mech Develop 2015; 136:64–72.
25. Sousa JF, Nam KT, Petersen CP, et al. MiR-30-HNF4gamma and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach. Gut 2015. pii: gutjnl-2014-308759.
26. Hu S, Wilson KD, Ghosh Z, et al. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells 2013; 31:259–268.